Concepedia

Emily Chan

EC

Statistics

Publications

71

Citations

10.1K

H-Index

38

Active since

1994

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

The University of Texas MD Anderson Cancer Center

Vanderbilt-Ingram Cancer Center

Memorial Sloan Kettering Cancer Center

Emily Chan is an author at Vanderbilt University Medical Center specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1994–2024

71

Publications

71

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations

David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text

, , +12

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

Christine H. Chung, Beloo Mirakhur, Emily Chan et al. · New England Journal of Medicine · 2008 · 1.5K citations · Full text

, , +15

Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer

Scott Kopetz, Jayesh Desai, Emily Chan et al. · Journal of Clinical Oncology · 2015 · 693 citations · Full text

, , +17

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

Padmanee Sharma, Margaret K. Callahan, Petri Bono et al. · The Lancet Oncology · 2016 · 685 citations · Full text

, , +12

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 415 citations · Full text

, , +17

1–5 of 71